Familial Clinical Heterogeneity of Medullary Thyroid Cancer with Germline RET S891A Protooncogene Mutation: 7-year Follow-up with Successful Sorafenib Treatment

Hereditary forms of medullary thyroid carcinoma (MTC) are rare. Different phenotypes with the same mutation may be due to differences in the timing of rearranged during transfection (RET) activation steps, additional mutations in other regions of the gene, or the co-occurrence of germline and somati...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Sirmen Kızılcan Çetin, Zeynep Şıklar, Elif Özsu, Ayşegül Ceran, Koray Ceyhan, Zehra Aycan, Ayça Kırmızı, Handan Dinçaslan, Emel Ünal, Merih Berberoğlu
Format:	Artigo
Jezik:	Inglês
Izdano:	Pediatric Endocrinology and Diabetes Society 2025-09-01
Serija:	JCRPE
Teme:	medullary thyroid carcinoma ret sorafenib
Online dostop:	https://www.jcrpe.org/articles/familial-clinical-heterogeneity-of-medullary-thyroid-cancer-with-germline-lessemgreaterretlessemgreater-s891a-protooncogene-mutation-7-year-follow-up-with-successful-sorafenib-treatment/doi/jcrpe.galenos.2023.2023-7-13
Oznake:	Označite Brez oznak, prvi označite!